On October 13, 2021, the AIDS Foundation of Chicago (AFC) and AVAC hosted Can Fantasies Become Realties? The Quest for Multi-purpose Prevention Products, a webinar featuring global expert Dr. Sharon Hillier and others. They discussed the need for products that not only prevent HIV but are contraceptive as well, or prevent other STIs – or all of the above. Fascinating science is currently underway, with some new interventions getting closer to prime time. Like the previous webinars in this series (Butt Stuff and Pleasure Buffet) – there was a DJ and also performers.
Avac Event
Can Fantasies Become Realties? The Quest for Multi-purpose Prevention Products
Avac Event
Imbokodo Vaccine Trial Results and Implications for the Field—A Global Discussion
Johnson & Johnson and partners announced that the Imbokodo study, a large-scale HIV vaccine proof-of-concept trial also known as HVTN 705/HPX2008, did not significantly reduce the overall risk of HIV acquisition among over 2,600 women in five sub-Saharan African countries.
On September 9, AVAC held a global webinar to discuss this development and the implications for the HIV vaccine field. Watch the recording.
Avac Event
Innovations and Challenges of PEPFAR Prevention Programming During the COVID-19 Pandemic
AVAC with the Global AIDS Policy Partnership (GAPP) hosted a global Zoom webinar on HIV prevention entitled: “Innovations and Challenges of PEPFAR Prevention Programming during the COVID-19 pandemic”
The webinar opened with a presentation by staff from the Office of the Global AIDS Coordinator on prevention programming, followed by a moderated panel discussion.
Speakers and Panelists
Sara Klucking, Senior Technical Adviser and Acting Director, Office of Research and Science, US Department of State, Office of the Global AIDS Coordinator and OGAC colleagues Janet Saul, Erin Eckstein and Jennifer Cole.
Panel Discussion Moderator: Keifer Buckingham, Open Society Foundations.
Panelists: Marineus Mutongore, Chair of the Key and Vulnerable Population Forum in Tanzania, Kudakwashe Murombedzi, Senior Technical Advisor for VMMC Communications on the USAID-funded EMPOWER project in Malawi and Sara Klucking, OGAC.
Webinar in Brief
The recent Global Fund Results report, as well as some early reports from PEPFAR countries, have suggested that HIV prevention activities have been more greatly affected as the COVID-19 pandemic has swept through many countries in Eastern and Southern Africa. This webinar explores how different PEPFAR prevention programs (the DREAMS program, voluntary medical male circumcision, PrEP and behavioral interventions) fared, and what innovations are being used to keep prevention on track.
Downloads
Avac Event
Advancing HIV Prevention & SRHR for Adolescent Girls and Young Women in the Time of COVID
On September 28, IPPFWHR and AVAC partners held the webinar Advancing HIV Prevention & SRHR for Adolescent Girls and Young Women in the Time of COVID. The webinar opened with remarks from Serra Sippel, Chief Global Advocacy Officer at IPPFWHR, and included a conversation with six young women advocates from Malawi, Tanzania and Zimbabwe. The panel was moderated by Liz Ford, Deputy Editor for The Guardian‘s Global Development website. The panelists were:
- Cathering Madebe – Mulika, Tanzania
- Dr. Lilian Mwakyosi – Tayoa, Tanzania
- Mtisunge Mikaya – MANASO, Malawi
- Sekani Tchuwa – Coalition of Women Living with HIV and AIDS, Malawi/li>
- Naledi Katsande – Youth for Health Promotion, Zimbabwe
- Queen Bee Meki – Trans & Intersex Rising, Zimbabwe
The recording will be posted shortly.
Avac Event
Integration of HIV and Sexual and Reproductive Health in the Era of ARV-Based Prevention: Findings from assessments in Kenya, Malawi and Zimbabwe
New research from AVAC and partners shows promising approaches to reach adolescent girls and young women (AGYW) with comprehensive and integrated services for HIV and sexual and reproductive health (SRH), including expanding access to existing and future PrEP products. On October 14, we were joined by representatives from the Ministries of Health in Kenya, Malawi and Zimbabwe for this webinar to discuss findings, progress to date and context-specific realities.
Moderators
- Jessica Rodrigues, AVAC
- Sara Allinder, Georgetown University Center for Innovation in Global Health
- Anna Miti, Humanitarian Information Facilitation Centre
Speakers
- Ruth Kamau, National AIDS & STI Control Programme (NASCOP), Ministry of Health, Kenya
- Fannie Kachale, Department of Reproductive Health, Ministry of Health, Malawi
- Getrude Ncube, Department of AIDS & TB, Ministry of Health and Child Care, Zimbabwe
- Jacque Wambui, AfroCAB Treatment Access Partnership, Kenya
- Barbra Ncube, Pangaea Zimbabwe AIDS Trust (PZAT), Zimbabwe
Downloads
Avac Event
Civil Society Round Table Discussion on Domestic Resource Mobilization for Health Research and Development
On October 14th, WACI Health led a roundtable discussion focused on domestic resource mobilization. WACI Health also unveiled a Situation Analysis Report on Domestic Resource Mobilization for Health Research and Development in Africa. The report was commissioned by WACI Health and partners in an effort to identify gaps, strengths and opportunities in health research funding. Among others, the report aims at informing strategy and advocacy for all stakeholders committed to expanding the resource envelope for health research and development (R&D) in Africa.
Avac Event
Diversity and Gender Equity in Health R&D
On October 12, the South Africa Health Technologies Advocacy Coalition (SAHTAC) in partnership with PATH and Campaigning for Cancer hosted the webinar Diversity and Gender Equity in Health R&D. The purpose of the webinar was to discuss and understand the barriers, challenges and how to achieve diversity and gender equity in Health R&D. The aim was also to understand and explore how to promote equitable access to health products. SAHTAC’s Primary Outcome 4 is targeting for increased salience of diversity and gender equity in health research. This outcome focusses on both diversity and gender equity in research participation and equitable access to health products. SAHTAC aims to strengthen champions (research participants, community stakeholders, scientists, CSOs, government) to advance issues regarding equitable access to health products.
Avac Event
Investment and Engagement in HIV Cure Research: Looking Ahead
On Wednesday, October 27th, we held a webinar to discuss the state of global HIV cure investment and how Martin Delaney Collaboratory (MDC) is making investments in cure research and working with communities. The webinar featured the growing investment in both the science and stakeholder engagement of HIV cure and included an overview of the HIV cure research funding landscape, a history of the MDC program and a panel discussion.
Speakers and Panelists
Speakers:
- Kevin Fisher, AVAC
- Karl Salzwedel, NIAID
Panel Moderator:
- Jessica Salzwedel, AVAC
Panelists:
- Dixon Diallo, SisterLove President & ERASE-HIV Community Partner (US)
- Dr. Deanna Kulpa, ERASE-HIV PI (US)
- Josephine Nabukenya, EGPAF & IAS-AVAC HIV Cure Fellow (Uganda)
Recording and Slides: YouTube / Kevin Fisher’s Slides / Karl Salzwedel’s Slides
Avac Event
Reality Check About “Global” COVID-19 Vaccine Production
On Thursday, November 4th, award-winning journalist Stephanie Nolen joined AVAC to discuss the findings and backstory of her recent New York Times investigation,”Here’s Why Developing Countries Can Make mRNA COVID Vaccines.” During the webinar, Stephanie, AVAC and partners explored where we are in the fight to bring COVID mRNA vaccine manufacturing to the places where doses are needed most, in countries where vaccine access has been grievously stalled. We also talked through her report and discussed the parallels with HIV.
Speakers:
- Mitchell Warren, AVAC
- Stephanie Nolen, New York Times
- Zain Rizvi, Public Citizen
Watch the recording and download the transcript.
Avac Event
What Does the Future Hold for Long Acting Injectable PrEP?
With long-acting injectable PrEP coming to market, how can we mitigate barriers and adopt the intervention widely in high-risk settings? On Wednesday, November 10, Evidence to Action, the webinar series hosted by the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), heard from experts at Johns Hopkins University, United States Agency for International Development (USAID), AVAC, Asia Pacific Coalition on Male Sexual Health (APCOM), and EGPAF on what’s new in PrEP, the present and future of long-acting injectables, what actions to take for optimal implementation and how we can better enable access in key populations.
Speakers to Include:
- Opening Remarks: Anja Giphart, EGPAF
- An overview of long-acting technologies and strategies in development for PrEP: Charles Flexner, Johns Hopkins University of Medicine
- Reflecting on implementation of biomedical prevention interventions to date in the context of implementation of long-acting injectables and new products: Robyn Eakle, USAID
- Priority actions to enable uptake of new products: Mitchell Warren, AVAC
- How this will effect key populations and how we work alongside key pops to drive awareness around technical and practical aspects: Midnight Poonkasetwatana, APCOM
- Concerns about making long term decisions on medication in the postpartum period: Dee Mphafi, EGPAF Youth Advocate
- Moderated Discussion: Natella Rakhmanina, EGPAF